$TKR

Morgan Stanley Adjusts Price Target on Timken to $160 From $140, Maintains Equalweight Rating

Morgan Stanley raised its price target on The Timken Company to $160 from $140 and kept an Equalweight rating, according to the note. Timken is a maker of engineered bearings and industrial motion products. The target change reflects the broker’s updated valuation and outlook inputs.

Original reporting
Published Aug 5, 2026, 10:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$TKR
Neutral
low confidence
Mentioned
$TKR
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$TKRNeutralLow
01

Why it matters

The only actionable item in the text is the Morgan Stanley price target increase paired with an Equalweight rating, which typically signals modest valuation upside but no change in stance.

02

Market read

This is an analyst target update with no accompanying fundamental datapoint in the provided text.

03

What to watch

Without any cited changes to earnings estimates, margins, or backlog, traders may discount the PT move as incremental.

Relevance 4/10Novelty 3/10Timing: analyst note dated 2026-08-05 10:14 UTC

Background

The article is a boilerplate description of Timken’s business segments and a summary of composite rating methodology, alongside the headline analyst PT change.

Company-level read

Ticker impact

$TKRNeutralLow confidence
Context

Morgan Stanley raised Timken’s price target to $160 from $140 while keeping an Equalweight rating, signaling a valuation view change for TKR.

Expected impact

Likely limited near-term impact, with any reaction more sentiment-driven than fundamental.

Evidence & confidence

The provided text contains only the PT change and rating maintenance, with no new earnings, guidance, or operational catalyst.

Market effects

Could marginally support sentiment for industrial bearings and motion-control names, but no sector-wide catalyst is described.

No regional macro or cross-market linkage is provided.

No global demand, supply-chain, or regulatory development is mentioned.

Counterpoint

A higher price target with unchanged Equalweight can reflect model recalibration rather than improved fundamentals, limiting follow-through.

Key entities

  • The Timken Company

    Engineered bearings and industrial motion products provider; subject of the analyst price-target adjustment.

  • Morgan Stanley

    Analyst firm that adjusted Timken’s price target while maintaining Equalweight.

Related articles

$TKRMed

The Timken Company Q2 2026 Earnings Call Summary

Timken reported Q2 2026 results driven by organic revenue growth of over 4%, higher pricing and volume, and record Industrial Motion sales. The company raised full-year 2026 adjusted EPS guidance to $6.05-$6.35 and expects ~2.5% organic growth in 2H. Management cited a $0.10 EPS headwind from aerospace and defense investments and a nonrecurring $8m ($0.08/share) tariff refund benefit.

$TKRMed

Timken Co. reports second-quarter sales increase

Timken Co. reported second-quarter sales of $1.26 billion, up 7.5% year over year, citing higher sales in both segments, pricing, currency translation, and Bijur Delimon acquisition revenue. Net income fell to $28.9 million (41 cents/share). Free cash flow was $80.5 million. Timken raised its dividend 3%, repurchased about 155,000 shares, and updated 2026 EPS guidance to $3.75-$4.05.

$TKRMed

Why Timken (TKR) Shares Are Plunging Today

Timken (NYSE: TKR) shares fell 7.8% after the company reported Q2 2026 results. The report beat sales estimates, but profitability declined, with operating margin dropping to 6.7% from 12.6% a year earlier. Investors focused on the margin contraction despite better revenue and adjusted EPS.